Oncogenic Viruses and Hepatocellular Carcinoma

被引:20
作者
Ben Ari, Ziv [1 ,2 ,3 ]
Weitzman, Ella [1 ,3 ]
Safran, Michel [1 ,2 ]
机构
[1] Chaim Sheba Med Ctr, Liver Dis Ctr, IL-52621 Ramat Gan, Israel
[2] Chaim Sheba Med Ctr, Liver Res Lab, IL-52621 Ramat Gan, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
Hepatocellular carcinoma; Oncogenic viruses; Hepatitis B; Hepatitis C; HEPATITIS-C-VIRUS; SUSTAINED VIROLOGICAL RESPONSE; NONSTRUCTURAL PROTEIN NS3; E-CADHERIN EXPRESSION; X-PROTEIN; LONG-TERM; CORE PROTEIN; ANTIVIRAL THERAPY; NONCIRRHOTIC PATIENTS; INTERFERON THERAPY;
D O I
10.1016/j.cld.2015.01.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
About 80% of hepatocellular carcinoma (HOC) is caused by hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections especially in the setting of established cirrhosis or advanced fibrosis, making HOC prevention a major goal of antiviral therapy. HOC tumors are highly complex and heterogeneous resulting from the aberrant function of multiple molecular pathways. The roles of HCV or HBV in promoting HOC development are still either directly or indirectly are still speculative, but the evidence for both effects is compelling. In patients with chronic hepatitis viral infection, cirrhosis is not a prerequisite for tumorigenesis.
引用
收藏
页码:341 / +
页数:21
相关论文
共 143 条
  • [1] Hepatitis C Virus-Associated Primary Hepatocellular Carcinoma in Non-cirrhotic Patients
    Albeldawi, Mazen
    Soliman, Mohamed
    Lopez, Rocio
    Zein, Nizar N.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (12) : 3265 - 3270
  • [2] A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis
    Aleman, Soo
    Rahbin, Nogol
    Weiland, Ola
    Davidsdottir, Loa
    Hedenstierna, Magnus
    Rose, Nina
    Verbaan, Hans
    Stal, Per
    Carlsson, Tony
    Norrgren, Hans
    Ekbom, Anders
    Granath, Fredrik
    Hultcrantz, Rolf
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) : 230 - 236
  • [3] Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer
    Arzumanyan, A.
    Friedman, T.
    Kotei, E.
    Ng, I. O. L.
    Lian, Z.
    Feitelson, M. A.
    [J]. ONCOGENE, 2012, 31 (05) : 563 - 572
  • [4] Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
    Arzumanyan, Alla
    Reis, Helena M. G. P. V.
    Feitelson, Mark A.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (02) : 123 - 135
  • [5] MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
    Bai, Shoumei
    Nasser, Mohd W.
    Wang, Bo
    Hsu, Shu-Hao
    Datta, Jharna
    Kutay, Huban
    Yadav, Arti
    Nuovo, Gerard
    Kumar, Pawan
    Ghoshal, Kalpana
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (46) : 32015 - 32027
  • [6] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [7] Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes
    Basu, Arnab
    Meyer, Keith
    Lai, Keith K.
    Saito, Kousuke
    Di Bisceglie, Adrian M.
    Grosso, Leonard E.
    Ray, Ratna B.
    Ray, Ranjit
    [J]. VIROLOGY, 2006, 349 (02) : 347 - 358
  • [8] HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment
    Benzoubir, Nassima
    Lejamtel, Charlene
    Battaglia, Serena
    Testoni, Barbara
    Benassi, Barbara
    Gondeau, Claire
    Perrin-Cocon, Laure
    Desterke, Christophe
    Thiers, Valerie
    Samuel, Didier
    Levrero, Massimo
    Brechot, Christian
    Bourgeade, Marie-Francoise
    [J]. JOURNAL OF HEPATOLOGY, 2013, 59 (06) : 1160 - 1168
  • [9] Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C
    Bruix, Jordi
    Poynard, Thierry
    Colombo, Massimo
    Schiff, Eugene
    Burak, Kelly
    Heathcote, Elizabeth J. L.
    Berg, Thomas
    Poo, Jorge-Luis
    Mello, Carlos Brandao
    Guenther, Rainer
    Niederau, Claus
    Terg, Ruben
    Bedossa, Pierre
    Boparai, Navdeep
    Griffel, Louis H.
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    [J]. GASTROENTEROLOGY, 2011, 140 (07) : 1990 - 1999
  • [10] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022